Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2025

Genmab — September 2025

Planlagt Fastgjort Låst Flyttet Genmab
283 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #130

    Genmab får købsanbefaling fra amerikansk børshus: Ser potentiale på 50 pct. https://proinvestor.com/investornyt/1364272/genmab-far-kobsanbefaling-fra-amerikansk-borshus-ser-potentiale-pa-50-pct

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #131

      Tak for den Helge:-)

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #132

        Genmab får ny storaktionær https://proinvestor.com/investornyt/1364304/genmab-far-ny-storaktionaer

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #133

          Orbis was set up in 1989. Our founder Allan Gray believed that a fundamental, contrarian long-term approach offered great potential. If he applied it successfully, he could help people grow their money meaningfully over time.

          Until 2015, our Funds were only available to institutions, like pension funds, with millions to invest. But we wanted to make investing in funds simpler and more accessible for everyone.

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #134

            Læs mere om den nye storaktionær: https://www.orbis.com/uk/individual/about-us/about-us

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bikube
              wrote on sidst redigeret af
              #135

              Er det ikke ca. 14 dage siden, at vi sidst snakkede om den nyhed.

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #136

                Børsmeddelelsen er kommet i dag.

                1 Reply Last reply
                0
                • R Offline
                  R Offline
                  Raun
                  wrote on sidst redigeret af
                  #137

                  Er der et modstandspunkt her 1820-1830 stykker - Synes det virker til at aktien har det svært i dette niveau?

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    Dusør
                    wrote on sidst redigeret af
                    #138

                    En lille pause efter 500 kr op på rekord tid. Så er den klar til et ryk mere, samme størrelse vil være fint.

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bikube
                      wrote on sidst redigeret af
                      #139

                      Vi så tidligere listen over de største aktionærer, og Orbis stod der med to fonde, der tilsammen havde over 5%.

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #140

                        Ok Bikube.

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #141

                          New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies https://www.prnewswire.com/news-releases/new-novartis-data-further-support-benefits-of-kesimpta-in-relapsing-ms-following-switch-from-oral-disease-modifying-therapies-302565142.html

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #142

                            Johnson & Johnson at Bernstein Forum: Strategic Growth and Innovation https://www.investing.com/news/transcripts/johnson--johnson-at-bernstein-forum-strategic-growth-and-innovation-93CH-4253958

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              lahn1
                              wrote on sidst redigeret af
                              #143

                              Var der noget nyt fra Pagano på Bank of America Global Health conference ?

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                GUHO
                                wrote on sidst redigeret af
                                #144

                                Thanks for the link EL. The outlook for Rybrevant seems very encouraging. As I understand it, they indicate that Rybrevant can reach 4 billion dollars as fast as in 2028 with a peak above 5 billion

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #145

                                  Ugekommentar. Genmab 07.32. Kort video: https://proinvestor.com/boards/128565

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #146

                                    Trump varsler 100 procents told på flere lægemidler https://proinvestor.com/investornyt/1365456/trump-varsler-100-procents-told-pa-flere-laegemidler

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #147

                                      Danske life science: Torsdagsklø, men hvad venter fredag? https://proinvestor.com/boards/128587

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #148

                                        a bit more on Guggenheim's thoughts - Genmab upgraded at Guggenheim; says Darzalex related growth concerns are overblown https://www.msn.com/en-us/money/markets/genmab-upgraded-at-guggenheim-says-darzalex-related-growth-concerns-are-overblown/ar-AA1N8I83

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #149

                                          Tak E L

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper